Blood Cancer Discovery

Follow Blood Cancer Discovery for high-impact articles on pace-setting advances of researchers and physician-scientists working globally. Published by @AACR.

[Blood Cancer Discovery @BCD_AACR]

The July issue is online. https://t.co/NnhkNx5AIk

[Blood Cancer Discovery @BCD_AACR]

The development of cancer-targeting agents and innovative therapeutic approaches play a vital role in the advancement of patient care and improving clinical outcomes. Read more in the updated Developmental Therapeutics article collection: https://t.co/LIFQ4O5lBa #AACRdrugdev26

[Blood Cancer Discovery @BCD_AACR]

Now online: The Nicotinamide Salvage Pathway is a Metabolic Vulnerability of High-Risk MDS Stem Cells https://t.co/8he643lZ1Z

[Blood Cancer Discovery @BCD_AACR]

Read the Pediatric Cancer article collection, highlighting impactful findings that lead to new therapies for a patient population that faces significant barriers to meaningful progress. https://t.co/IKeiVK4mnE

[Blood Cancer Discovery @BCD_AACR]

Now online: Genomic Features Do Not Account for Differences in Multiple Myeloma Risk by Ancestry https://t.co/TiNMFPAdtW

[Blood Cancer Discovery @BCD_AACR]

Now online: Safety and clinical outcomes of a first-in-human trial of point-of-care manufactured trispecific CAR T cells targeting CD19, CD20, and CD22 https://t.co/nYMRHFUyeR

[Blood Cancer Discovery @BCD_AACR]

Now online: BTK Degraders in Lymphoid Malignancies: New Modality, New Resistance Rules? https://t.co/W3FEisyavK

[Blood Cancer Discovery @BCD_AACR]

Read the Myeloid Neoplasms collection: https://t.co/c3Pn2Gy4Mf

This collection showcases recent advances in fundamental and clinical research on myeloid neoplasms published in Blood Cancer Discovery.

[Blood Cancer Discovery @BCD_AACR]

Multiomic and Longitudinal Dissection of Immune Dynamics Associated with Parkinsonism after Ciltacabtagene Autoleucel Therapy
https://t.co/R8KRT2w0p7 @AE_Saliba

[Blood Cancer Discovery @BCD_AACR]

Now online: Genetic Mutation and Epigenetic Silencing Drive Antigen-Negative Relapse in CD7 CAR-T Treated T-cell Lymphoid Malignancies https://t.co/ZfsSNNGK0B

[Blood Cancer Discovery @BCD_AACR]

#InTheSpotlight KATs in the MYST: A New Therapeutic Vulnerability for SETBP1-Mutated Myeloid Malignancies https://t.co/PsBkrTstcI @Gritsman_lab

[Blood Cancer Discovery @BCD_AACR]

Check out the updated Lymphoma collection: https://t.co/PH1w1Ejuvt

[AACR @AACR]

The AACR special conference on Advances in Malignant Lymphoma showcased the full spectrum of lymphoma research from discovery to clinical impact. Get the highlights on the #AACRBlog: https://t.co/Ruhqhj1bCY @GreenLymphoLab @UTMDAnderson #AACRlymphoma26

[Blood Cancer Discovery @BCD_AACR]

Read the latest Editors' Pick: Debulking Chemotherapy Can Overcome Primary Resistance to Teclistamab in Relapsed/Refractory Multiple Myeloma https://t.co/T9XNJw7tc4

[AACR @AACR]

Studies on targeting neural cross-talk to stop glioblastoma recurrence, a vaccine to prevent colorectal cancer, and other advances were included in the June edition of Editors’ Picks from the AACR journals. Learn more on the AACR Blog: https://t.co/46JQ2yzzf0

[Blood Cancer Discovery @BCD_AACR]

Did you know: members of the Hematologic Malignancies AACR Working Group can receive an additional discount on publishing fees.
➡️Learn more: https://t.co/aYTcjuiy3F

[Blood Cancer Discovery @BCD_AACR]

Keep up with the latest Blood Cancer Discovery issues by getting alerts sent directly to your inbox.

➡️Sign up: https://t.co/88mGBIndq3

[Blood Cancer Discovery @BCD_AACR]

Conference chair Michael Green featured his Research Article, "A Patient-Derived Xenograft Repository Capturing Clinical and Molecular Heterogeneity of Large B-cell Lymphoma," during his talk Saturday at #AACRlymphoma26. Read it here: https://t.co/jyXk4kUBwa @GreenLymphoLab

[Blood Cancer Discovery @BCD_AACR]

Clinical cancer research featuring science-based clinical trials is an area of significant growth that aims to determine efficacy and safety of drugs and treatment regimens. Read more in the Clinical Research and Trials article collection: https://t.co/sSqCAeKGEI

[Blood Cancer Discovery @BCD_AACR]

Anand Jeyasekharan referenced his In Focus, "Single-cell Resolved Oncogene Co-expression: From Principles to Clinical Impact," during the Workshop on Leveraging Spatial Technologies in Lymphoma at #AACRlymphoma26. Read it here: https://t.co/U5j2zHduwg

[Blood Cancer Discovery @BCD_AACR]

Marcela Maus mentioned her paper, "Blockade or Deletion of IFNγ Reduces Macrophage Activation without Compromising CAR T-cell Function in Hematologic Malignancies" during her talk about CAR T cell therapy for lymphomas at #AACRlymphoma26. Read it here: https://t.co/6QTvagB7ba

[Blood Cancer Discovery @BCD_AACR]

Marcela Maus referenced the In Foucs, "Potential Role of IFNγ Inhibition in Refractory Cytokine Release Syndrome Associated with CAR T-cell Therapy," during her talk at #AACRlymphoma26. Read the featured paper: https://t.co/kuJb9Dqp93